Table 1.
Demographic and clinical characteristics of MIS-C patients
| Patients (n:34) | |
|---|---|
| Gender | |
| Female (n, %) | 17 (50) |
| Male (n, %) | 17 (50) |
| Age, years, (mean ± SD) | 9.31 ± 4.72 |
| BMI, Z score (mean ± SD) | 0.29 ± 1.36 |
| COVID-19 IgM and/or IgG antibodies (n, %) | 34 (100) |
| History of previous COVID-19 disease | 3 (8.8) |
| Family history of COVID-19 | 12 (35.3) |
| The age distribution, n (%) | |
| 1 to < 5 years | 8 (23.5) |
| 5 to < 15 years | 21 (61.8) |
| > 15 years | 5 (14.7) |
| Underlying diseases, n (%) | – |
| Previously healthy | 34 (100) |
| Signs and symptoms, n (%) | |
| Fever | 34 (100) |
| Maculopapular rash | 19 (55.9) |
| Conjunctivitis | 17 (50) |
| Vomiting | 14 (41.2) |
| Diarrhea | 11 (32.2) |
| System involvement | |
| Cardiovascular | 24 (70.6) |
| Hematological | 22 (64.7) |
| Gastrointestinal | 21 (61.8) |
| Renal | 6 (17.6) |
| Neurological | 4 (11.8) |
| The total length of hospital stay, days, mean ± SD | 11.6 ± 5.3 |
| Length of PICU stay, days, mean ± SD | 3.6 ± 2.4 |
| Treatment, n (%) | |
| IVIG | 33 (97.1) |
| Steroid | 27 (79.4) |
| Anakinra | 3 (8.8) |
| Oxygen support, n (%) | 11 (32.4) |
| PICU admission, n (%) | 17 (50) |
SD standard deviation, BMI body mass index, Ig immunoglobulin, IVIG intravenous immunoglobulin, PICU pediatric intensive care unit